Literature DB >> 3472503

Association of non-viral proteins with recombinant vaccinia virus virions.

C A Franke, D E Hruby.   

Abstract

Evidence is presented which suggests that recombinant vaccinia virus particles (VV:CAT), containing the bacterial chloramphenicol acetyl transferase gene, are capable of encapsidating both the foreign protein which they encode (CAT) as well as cellular enzymes such as thymidine kinase. These results are discussed with respect to using VV to passively introduce biologically-active proteins into cells or organisms.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3472503     DOI： 10.1007/BF01310729

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  11 in total

1.  Detection of a subunit of cellular Pol II within highly purified preparations of RNA polymerase isolated from rabbit poxvirus virions.

Authors:  D K Morrison; R W Moyer
Journal:  Cell       Date:  1986-02-28       Impact factor: 41.582

2.  In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals.

Authors:  M A Cochran; C Puckett; B Moss
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

3.  Cell-free synthesis of enzymatically active vaccinia virus thymidine kinase.

Authors:  D E Hruby; L A Ball
Journal:  Virology       Date:  1981-09       Impact factor: 3.616

4.  Vaccinia virus replication. I. Requirement for the host-cell nucleus.

Authors:  D E Hruby; L A Guarino; J R Kates
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

5.  Inhibition of HeLa cell protein synthesis by the vaccinia virion.

Authors:  B Moss
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

6.  Recombinant vaccinia viruses as vaccines.

Authors:  F Brown; G C Schild; G L Ada
Journal:  Nature       Date:  1986 Feb 13-19       Impact factor: 49.962

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions.

Authors:  G Rohrmann; B Moss
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

9.  Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions.

Authors:  C M Rice; C A Franke; J H Strauss; D E Hruby
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

10.  Expression and cell type--specific processing of human preproenkephalin with a vaccinia recombinant.

Authors:  G Thomas; E Herbert; D E Hruby
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728
View more
  10 in total

1.  Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.

Authors:  Reuben K Soi; Fred R Rurangirwa; Travis C McGuire; Paul M Rwambo; James C DeMartini; Timothy B Crawford
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

Review 2.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

3.  Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.

Authors:  J Musil; L Kutinova; K Zurkova; P Hainz; K Babiarova; J Krystofova; S Nemeckova
Journal:  Cancer Gene Ther       Date:  2014-02-21       Impact factor: 5.987

Review 4.  Vaccinia virus vectors: new strategies for producing recombinant vaccines.

Authors:  D E Hruby
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

5.  Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Authors:  Nissin Moussatche; Richard C Condit
Journal:  Virology       Date:  2014-12-08       Impact factor: 3.616

6.  Attenuation of vaccinia virus by the expression of human Flt3 ligand.

Authors:  Kamila Zurkova; Petr Hainz; Jitka Krystofova; Luda Kutinova; Miloslav Sanda; Sarka Nemeckova
Journal:  Virol J       Date:  2010-05-26       Impact factor: 4.099

7.  Vaccinia virus recombinants expressing an 11-kilodalton beta-galactosidase fusion protein incorporate active beta-galactosidase in virus particles.

Authors:  C Huang; W A Samsonoff; A Grzelecki
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

8.  Characterization of a binding factor that interacts with the sequences upstream of the vaccinia virus thymidine kinase gene.

Authors:  E M Wilson; C Edbauer; D E Hruby
Journal:  Virus Genes       Date:  1988-10       Impact factor: 2.332

9.  Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.

Authors:  Che-Sheng Chung; Chein-Hung Chen; Ming-Yi Ho; Cheng-Yen Huang; Chung-Lin Liao; Wen Chang
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.

Authors:  Nanhai Chen; Clifford J Bellone; Jill Schriewer; Gelita Owens; Torgny Fredrickson; Scott Parker; R Mark L Buller
Journal:  Virology       Date:  2010-11-10       Impact factor: 3.513
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.